Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average
Getinge updates its financial target for adjusted EPS growth 2024-2028 to be above 12% on average. The target takes into account today’s decisions (see below) that follow from the letter that the U.S. Food and Drug Administration (FDA) sent to healthcare providers in the US on May 8th.In the letter from the U.S. FDA, there are no new field actions referred to, but healthcare providers are advised to transition from Getinge’s Cardiosave Intra-Aortic Balloon Pump (IABP), Cardiohelp System, and HLS Sets Advanced to alternative products, and to continue using Getinge’s products only if no other
Teollisuuden Voima Oyj (TVO) has priced a EUR 600 million green bond and announced a tender offer for its Eurobond maturing in February 2025.TVO has launched a EUR 600 million seven-year green bond with an annual coupon of 4.25 percent. The bond will be issued under the Company’s EMTN programme and will be listed on the Luxembourg Stock Exchange.
The net proceeds of the Green Bond issued by TVO will finance or refinance, in whole or in part, Eligible Green Projects in accordance with TVO’s Green Bond Framework, published in June 2023.
On 13 May 2024, TVO separately announced that it